Mounjaro shows promise for young patients with Type 2 diabetes and obesity. A recent study reveals its active ingredient, ...
Sabudana, a popular Indian snack, poses risks for diabetics due to its high starch content. It rapidly increases blood sugar ...
Glooko is looking to expand its diabetes treatment platforms to the inpatient setting, with a plan to acquire Monarch Medical ...
Medical Device Network on MSN
Glooko acquires Monarch to advance diabetes platform reach
Diabetes software company Glooko has acquired Monarch Medical Technologies in a move that will help the company to expand its ...
Join CMC's cookery competition in Vellore on September 27 to celebrate World Diabetes Day with healthy, delicious meals.
Mohan, India’s leading diabetologist, sheds light into a pioneering clinical trial conducted by the Madras Diabetes Research ...
A Novo Nordisk designed trial reports that their 25 mg oral semaglutide taken once daily produced greater mean weight ...
A much-publicised 2024 clinical trial that claimed apple cider vinegar (ACV) could help overweight people shed significant ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have rapidly emerged as highly effective pharmacological tools for ...
Aphaia’s lead formulation orchestrates a comprehensive hormonal response from nutrient-sensing cells with potential to modify the course of obesity and associated metabolic diseases.It is currently ...
Traditionally used to relieve constipation and support digestion, it is now gaining attention for its potential to lower ...
AI applications are a promising solution for PAD that may translate into earlier detection, customized risk assessment, and improved outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback